Botanical species · safety record

Spondias mombin

The EFSA Compendium of Botanicals holds 14 constituent measurements and 4 adverse-effect records for Spondias mombin. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Spondias mombin L.

14Constituent measurements

4Safety records

7Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Anacardic acid	Leaves	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	Resolve DOI
Alkaloids	Leaves	Solvent extraction	≥ 3.3 Percent	Phytochemical screening	No resolvable identifier
Alkaloids	Leaves	Solvent extraction	≤ 3.5 Percent	Phytochemical screening	No resolvable identifier
Cyanogenic glycosides	Leaves	Solvent extraction	0.01 Percent	Phytochemical screening	No resolvable identifier
Oxalates	Leaves	Solvent extraction	≥ 0.83 Percent	Phytochemical screening	No resolvable identifier
Oxalates	Leaves	Solvent extraction	≤ 1.01 Percent	Phytochemical screening	No resolvable identifier
Phytic acid	Leaves	Solvent extraction	≥ 1.54 Percent	Phytochemical screening	No resolvable identifier
Phytic acid	Leaves	Solvent extraction	≤ 1.92 Percent	Phytochemical screening	No resolvable identifier
Saponins	Leaves	Solvent extraction	≥ 4.55 Percent	Phytochemical screening	No resolvable identifier
Saponins	Leaves	Solvent extraction	0.22 Percent	Gaschromatography (GC)	No resolvable identifier
Saponins	Leaves	Solvent extraction	≤ 5.15 Percent	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Reproductive	Testes	Stem / stalk	Solvent extraction	Rat (as animal)	Reproduction toxicity	Resolve DOI
Reproductive	Testes	Stem / stalk	Solvent extraction	Rat (as animal)	Reproduction toxicity	Resolve DOI
Reproductive	Urogenital	Leaves	Solvent extraction	Rat (as animal)	Reproduction toxicity	Resolve DOI
Reproductive	Urogenital	Leaves	Solvent extraction	Rat (as animal)	Reproduction toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Raji, Y., Gbadegesin, M.A., Osonuga, O.A., Adisa, R.A., Akinsomisoye, O.S., Awobajo, F.O., Kunle-Alabi, O.T., Esegbue Peters, P.R.C., Osonuga, I.O., Lamidi, A.F. Reproductive, haematologic and biochemical profiles of male rats treated with aqueous extract of Spondias mombin bark. International Journal of Pharmacology, 2006, vol. 2, no. 1, p. 126-130. DOI
Asuquo, O.R., Oko, O.O.K., Brownson, E.S., Umoetuk, G.B., Utin, I.S. Effects of ethanolic leaf extract of Spondias mombin on the pituitary-gonadal axis of female Wistar rats. Asian pacific journal of reproduction, 2013, vol. 2, no. 3, p. 169-173. DOI
Ayoka, AO., Akomolafe, RO., Iwalewa, EO., Akanmu, MA., Ukponmwan, OE. Sedative, antiepileptic and antipsychotic effects of Spondias mombin L. (Anacardiaceae) in mice and rats. JOURNAL OF ETHNOPHARMACOLOGY, 2006, vol. 103, no. 2, p. 166-175. DOI
Igwe, C.U., Onyeze, G.O.C., Onwuliri, V.A., Osuagwu, C.G., Ojiako, A.O. Evaluation of the chemical compositions of the leaf of Spondias mombin linn from Nigeria. Australian Journal of Basic and Applied Sciences, 2010, vol. 4, no. 5, p. 706-710.
Nworu, C. S., Akah, P. A., Okoli, C. O., Okoye, T. C. Oxytocic activity of leaf extract of Spondias mombin. PHARMACEUTICAL BIOLOGY, 2007, vol. 45, no. 5, p. 366-371. DOI
El Fiki, N. M. Chemical composition and biological activity of Spondias lutea L. cultivated in Egypt. Al-azhar journal of pharmaceutical sciences, 2000, p. 206-221.
COATES, NJ., GILPIN, ML., GWYNN, MN., LEWIS, DE., MILNER, PH., SPEAR, SR., TYLER, JW. SB-202742, A NOVEL BETA-LACTAMASE INHIBITOR ISOLATED FROM SPONDIAS MOMBIN . Journal of natural products, 1994, vol. 57, no. 5, p. 654-657. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature